The Goldilocks paradox: when partial oncoprotein inhibition fuels metastasis in Ewing sarcoma
Targeting oncogenic fusion proteins remains a major challenge in pediatric oncology. In this issue of EMBO Molecular Medicine, Suresh et al (2025) demonstrate that incomplete inhibition of EWS::FLI1 in Ewing sarcoma paradoxically promotes metastatic behavior, revealing critical implications for therapeutic strategies. JY Blay & colleagues discuss the study by Suresh et al, in this issue of EMBO Mol Med, that shows that incomplete inhibition of EWS::FLI1 in Ewing sarcoma paradoxically promotes metastatic behavior.
Authors
- Marie Castets
- Jean-Yves Blay
- Adrien Bertrand-Chapel
Institutions
- Centre Léon Bérard (FR)
Publication Details
- Journal
- EMBO Molecular Medicine
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1038/s44321-025-00365-6
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Institut National Du Cancer
- Direction Générale de l’offre de Soins
- European Network for Rare Adult Solid Cancers